Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Pulsipher

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 23, 2012
National marrow donor program session: donor issuesWillis H Navarro, Galen E Switzer, Michael Pulsipher
Leukemia & Lymphoma|August 19, 2007
Incidence, risk factors, and pathogenesis of second malignancies in patients with non-Hodgkin lymphomaJonathan Tward, Martha Glenn, Michael Pulsipher, et al.
British Journal of Haematology|August 4, 2004
Successful reduced-intensity allogeneic transplantation utilizing a fludarabine-based preparative regimen in a patient with chronic lymphocytic leukaemia and a history of fludarabine-associated autoimmune haemolytic anaemiaClyde D Ford, Julie Asch, Michael Pulsipher, et al.
Journal of Pediatric Hematology/Oncology|July 9, 2003
Reduced toxicity and prompt engraftment after minimal conditioning of a patient with Fanconi anemia undergoing hematopoietic stem cell transplantation from an HLA-matched unrelated donorPeter Kurre, Michael Pulsipher, Ann Woolfrey, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 11, 2013
Exposure of early pediatric trainees to blood and marrow transplantation leads to higher recruitment to the fieldEvan Shereck, Shalini Shenoy, Michael Pulsipher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2006
High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival updateRani E George, Shuli Li, Cheryl Medeiros-Nancarrow, et al.
Cancer|March 4, 2008
Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantationMohamed Sorror, Barry Storer, Brenda M Sandmaier, et al.
Blood|August 12, 2004
Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphomaMichael B Maris, Brenda M Sandmaier, Barry E Storer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 10, 2020
Clonal Hematopoiesis in Related Allogeneic Transplant Donors: Implications for Screening and ManagementMatthew D Seftel, Michelle Kuxhausen, Linda Burns, et al.
Blood|April 9, 2014
Effect of body mass in children with hematologic malignancies undergoing allogeneic bone marrow transplantationRichard Aplenc, Mei-Jie Zhang, Lillian Sung, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 23, 2012
National marrow donor program session: donor issuesWillis H Navarro, Galen E Switzer, Michael Pulsipher
Leukemia & Lymphoma|August 19, 2007
Incidence, risk factors, and pathogenesis of second malignancies in patients with non-Hodgkin lymphomaJonathan Tward, Martha Glenn, Michael Pulsipher, et al.
British Journal of Haematology|August 4, 2004
Successful reduced-intensity allogeneic transplantation utilizing a fludarabine-based preparative regimen in a patient with chronic lymphocytic leukaemia and a history of fludarabine-associated autoimmune haemolytic anaemiaClyde D Ford, Julie Asch, Michael Pulsipher, et al.
Journal of Pediatric Hematology/Oncology|July 9, 2003
Reduced toxicity and prompt engraftment after minimal conditioning of a patient with Fanconi anemia undergoing hematopoietic stem cell transplantation from an HLA-matched unrelated donorPeter Kurre, Michael Pulsipher, Ann Woolfrey, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 11, 2013
Exposure of early pediatric trainees to blood and marrow transplantation leads to higher recruitment to the fieldEvan Shereck, Shalini Shenoy, Michael Pulsipher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2006
High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival updateRani E George, Shuli Li, Cheryl Medeiros-Nancarrow, et al.
Cancer|March 4, 2008
Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantationMohamed Sorror, Barry Storer, Brenda M Sandmaier, et al.
Blood|August 12, 2004
Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphomaMichael B Maris, Brenda M Sandmaier, Barry E Storer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 10, 2020
Clonal Hematopoiesis in Related Allogeneic Transplant Donors: Implications for Screening and ManagementMatthew D Seftel, Michelle Kuxhausen, Linda Burns, et al.
Blood|April 9, 2014
Effect of body mass in children with hematologic malignancies undergoing allogeneic bone marrow transplantationRichard Aplenc, Mei-Jie Zhang, Lillian Sung, et al.
Pageof 3